EsquireTradingCo
Posted - 7 hours ago
$OTLK In this strange market, pumps before catalysts sell off and drops reverse. That's been my experience anyhow. Good luck.
Dragos
Posted - 1 day ago
$OTLK new investor here, I've been passively watching this company for years, now I decided to buy for the first time. I have my worries about the execution, as I wonder if the FDA initial rejection could have been predicted and avoided, by e.g. a better planning of the trials. However, I think there is a lot of potential here.
opportoni
Posted - 1 day ago
$OTLK
EsquireTradingCo
Posted - 2 days ago
$OTLK I saw OKLO and almost had a heart attack thinking it was us.
Kylian7
Posted - 2 days ago
$OTLK Last call....
OTLKforecast
Posted - 2 days ago
$OTLK Just got in for another 2100 shares. I pray to God the EU comes through. If it does, the FDA is a done deal.
EsquireTradingCo
Posted - 2 days ago
$OTLK Inaugural conference call tells me they have something big to report next week. Just re-entered.
GenerallyGentle
Posted - 2 days ago
$OTLK Ohhhh.. it is coming into my area to add. $7.50 looks tasty. Lets see how it reacts around this price area, could still go lower.
opportoni
Posted - 2 days ago
$OTLK Their 2nd quarter ended on March 31 if I am not mistaken. The due date for the 10-Q would be May 15, accordingly. Why do they announce earnings report and conference call for the 16th? Do they need those additional hours to include some info they are expecting to receive on the 15th?
https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeuticsr-report-financial-results-second-quarter
Brionbee
Posted - 3 days ago
$OTLK I should have averaged down when it was under $8 today!!! I'll be so happy I was doing this together with you guys in about 2-3 weeks ;)
Bullfurlife
Posted - 3 days ago
$OTLK does this worry anybody? All institutional positions closed this week.
OnlyOneLife81
Posted - 3 days ago
$OTLK Low volume and price pushed down for a few days now. That's a classic move... You know what comes next, right? Getting closer and closer...
Multi_Millions
Posted - 3 days ago
$OTLK what a great buying opportunity don’t miss out!
Tanny86
Posted - 3 days ago
$OTLK Still waiting ..
Stock_Titan
Posted - 3 days ago
$OTLK $OTLKW Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast https://www.stocktitan.net/news/OTLK/outlook-therapeutics-r-to-report-financial-results-for-second-ug9dyuywk0ys.html
AOMFAOU
Posted - 4 days ago
$OTLK The biggest news I have ever read on this board and not many noticed..options launched! I've been gobbling up $12.50 calls for June since and I am full. Longs, if you have powder utilize the leverage of options contracts to max your leverage! Many have been hedging their long bets w/ puts. But I'm all in and just soaked up all the calls I could. If you need help understand options, DM me. But don't miss out on the opportunity.
Multi_Millions
Posted - 4 days ago
$OTLK 1000 shares at 8.35$ let’s gooooo
opportoni
Posted - 4 days ago
$OTLK While we wait for the final EU approval, here is some research on the ophthalmic off-label use of bevacizumab in the EU.
Subject to a good pricing strategy I would expect OTLK to take most of that market as doctors don’t like the liability risks associated with off-label use. Some shift from other approved bit more expensive therapies is also to be expected.
https://link.springer.com/article/10.1007/s00417-019-04569-8
GenerallyGentle
Posted - 5 days ago
$OTLK revisited the chart since I have not in a long while. chop chop chop ... market is buying time and awaiting more information. i will be watching for a daily close above $9.50 again to be truly bullish.
Investing4Knowledge
Posted - 5 days ago
$ATNM - this company is filled with 'Buy Ratings' from analysts and increases in price targets. The more I dig the more I like it. From a year-to-date view, the chart also looks very bullish and is looking to make new highs once it's able to break that $9.50's range. Still holding $GNPX.
Other potential stocks of interest are: $OTLK, $CRDF, & $AXSM.
Multi_Millions
Posted - 5 days ago
$OTLK I’m pretty much all in here! I keep money aside in case this drop below 8 for no reason and I wait for approval! Easy money in my opinion. Good luck bulls
OnlyOneLife81
Posted - 5 days ago
$OTLK @GenerallyGentle This is the calm before the storm... it is a waiting game. No BS, it is going to be approved sooner than later. From here, I see the price only going up. Longs here are just taking a break for now. Relaxing 😌
GenerallyGentle
Posted - 5 days ago
$OTLK so quiet lately here. Where did Wiz go ? He has been MIA since positive opinion from EU. Wiz you still around bud? Not going to lie, I miss reading your posts. Hope all is well.
Multi_Millions
Posted - 6 days ago
$OTLK why the bid is at 11.49?? 🤔
Fireballz
Posted - 1 week ago
$otlk
Here is the letter. Because the link seems too long text to work
Fireballz
Posted - 1 week ago
$otlk
Here is the risk analysis
Fireballz
Posted - 1 week ago
$otlk seems link is not able to open: second attempt
https://www.horizonscangeneesmiddelen.nl/binaries/content/assets/horizonscan/sluisadviezen/sluisadvies-lytenava-nav-chmp-maart-2024.pdf
Fireballz
Posted - 1 week ago
$otlk the basis for the recommendation is cost different, absence of non inferiority, and insight regarding side effects
https://www.horizonscangeneesmiddelen.nl/nieuws/advies-sluisplaatsing-lytenava-ooginjectie
Fireballz
Posted - 1 week ago
$OTLK the European commission is meeting weekly on a Wednesday’s in Brussels or occasionally on a Tuesdays in Strasbourg.
That implies EMA approval is to be expected on the 8th, 15th or 22nd of May.
Fireballz
Posted - 1 week ago
$OTLK if people are able to read it. This letter is a recommendation to the dutch minister to keep compounding avastin as first line treatment for now with the assumption that lytenava will have a comparable price with ranibizumab (€631,40) And therewith is assumed to be expensive.
Criteria for that is a cost of >20m euro for insurance companies. In all cases lytenava will check this box in NL since the threshold would be 156€ per inj x 6.7 (amount of inj in year 1 x 19019 (assumed amount of patients)
https://www.horizonscangeneesmiddelen.nl/binaries/content/assets/horizonscan/sluisadviezen/sluisadvies-lytenava-nav-chmp-maart-2024.pdf